(Q37964009)

26 August 2017

title

Recent derivatives from smaller classes of fermentation-derived antibacterials (English)

1 reference

26 August 2017

Herbert A Kirst

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

3 December 2011

1 reference

Expert Opinion on Therapeutic Patents

26 August 2017

published in

1 reference

26 August 2017

volume

22

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

15-35

1 reference

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Origins and evolution of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antibiotics versus resistant bacteria: a continual challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antibiotics for emerging pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antibiotic discovery in the twenty-first century: current trends and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antibiotics in the clinical pipeline in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Microbial drug discovery: 80 years of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antibiotics: natural products essential to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antibiotic Substances From Basidiomycetes: VIII. Pleurotus Multilus (Fr.) Sacc. and Pleurotus Passeckerianus Pilat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Mutilins derivatives: from veterinary to human-used antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

The activity and compatibility of the antibiotic tiamulin with other drugs in poultry medicine--A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Pleuromutilin derivatives having a purine ring. Part 2: influence of the central spacer on the antibacterial activity against Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Daptomycin: pharmacology and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Production of novel lipopeptide antibiotics related to A54145 by Streptomyces fradiae mutants blocked in biosynthesis of modified amino acids and assignment of lptJ, lptK and lptL gene functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

The structural diversity of acidic lipopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Natural products to drugs: daptomycin and related lipopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Synthetic lipopeptides: a novel class of anti-infectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Mechanism of action and limited cross-resistance of new lipopeptide MX-2401.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

New information about the polymyxin/colistin class of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Colistin in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Structure--activity relationships of polymyxin antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Structure-activity studies on novel polymyxin derivatives that carry only three positive charges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Polymyxins and their novel derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the Trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Development of des-fatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

From amino acids to heteroaromatics--thiopeptide antibiotics, nature's heterocyclic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

21 January 2018

Thiopeptide antibiotics

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Total synthesis of thiostrepton, part 2: construction of the quinaldic acid macrocycle and final stages of the synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Recent advances in thiopeptide antibiotic biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Thiopeptide antibiotic biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Thiopeptide biosynthesis featuring ribosomally synthesized precursor peptides and conserved posttranslational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Biosynthesis of indolocarbazole and goadsporin, two different heterocyclic antibiotics produced by actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Radical-mediated enzymatic carbon chain fragmentation-recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Discovery of a biologically active thiostrepton fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Structure-based design of agents targeting the bacterial ribosome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Mapping the binding site of thiopeptide antibiotics by proximity-induced covalent capture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Peptide deformylase as an antibacterial target: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

New screens and targets in antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Rifamycins--obstacles and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Update in tuberculosis 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

DNA minor groove binders as potential antitumor and antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Distamycins: strategies for possible enhancement of activity and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Distamycin analogues with enhanced lipophilicity: synthesis and antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antimicrobial lexitropsins containing amide, amidine, and alkene linking groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

MraY Inhibitors as Novel Antibacterial Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Total synthesis of (-)-muraymycin D2 and its epimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Synthetic study of muraymycins using Ugi-four component reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Identification of the gene cluster involved in muraymycin biosynthesis from Streptomyces sp. NRRL 30471.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Identification and manipulation of the caprazamycin gene cluster lead to new simplified liponucleoside antibiotics and give insights into the biosynthetic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Analysis of the liposidomycin gene cluster leads to the identification of new caprazamycin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

An ATP-independent strategy for amide bond formation in antibiotic biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

In vitro antimycobacterial activities of capuramycin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Chemical modification of capuramycins to enhance antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Concise synthesis of capuramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Crystal structures of blasticidin S deaminase (BSD): implications for dynamic properties of catalytic zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Natural products--the future scaffolds for novel antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Scaffold diversity of natural products: inspiration for combinatorial library design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Novel chemical space exploration via natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Engineering antibiotic production and overcoming bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Novel classes of antibiotics or more of the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

‘Aerosporin’, an Antibiotic Produced by Bacillus aerosporus Greer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Actinonin: an Antibiotic Substance produced by an Actinomycete

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

Structure and Synthesis of Distamycin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2012.642370

10.1517/13543776.2012.642370

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference